Variant report

Variant	esv3351730
Chromosome Location	chr1:161055728-161059526
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:59)
CpG islands
(count:244)
Chromatin interactive
region (count:9)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:59 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr1:161059080-161059230	SAEC	small airway:	n/a	n/a
2	CTCF	chr1:161059100-161059250	NHEK	skin:	n/a	n/a
3	CTCF	chr1:161059200-161059350	HMEC	breast:	n/a	n/a
4	CTCF	chr1:161059089-161059341	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr1:161058860-161059010	Caco-2	colon:	n/a	n/a
6	CTCF	chr1:161059140-161059290	GM12871	blood:	n/a	n/a
7	CTCF	chr1:161059120-161059270	SAEC	small airway:	n/a	n/a
8	CTCF	chr1:161059100-161059250	GM12870	blood:	n/a	n/a
9	CTCF	chr1:161059179-161059284	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr1:161059180-161059330	NHEK	skin:	n/a	n/a
11	ELK1	chr1:161058592-161058691	Hela-S3	cervix:	n/a	n/a
12	EP300	chr1:161059008-161059684	ECC-1	luminal epithelium:	n/a	n/a
13	EP300	chr1:161059109-161059610	T-47D	breast:	n/a	n/a
14	EP300	chr1:161059084-161059637	T-47D	breast:	n/a	n/a
15	FOS	chr1:161058447-161058720	MCF10A-Er-Src	breast:	n/a	chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595
16	FOS	chr1:161058437-161058732	MCF10A-Er-Src	breast:	n/a	chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595
17	FOS	chr1:161058447-161058719	MCF10A-Er-Src	breast:	n/a	chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595
18	FOS	chr1:161058432-161058758	MCF10A-Er-Src	breast:	n/a	chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595
19	FOSL2	chr1:161058345-161058742	A549	lung:	n/a	chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595 chr1:161058585-161058595
20	FOXA1	chr1:161059170-161059524	T-47D	breast:	n/a	n/a
21	GATA3	chr1:161059230-161059493	T-47D	breast:	n/a	n/a
22	GATA3	chr1:161059131-161059534	T-47D	breast:	n/a	n/a
23	HDAC2	chr1:161059138-161059610	MCF-7	breast:	n/a	n/a
24	HDAC2	chr1:161059082-161059671	MCF-7	breast:	n/a	n/a
25	JUND	chr1:161059258-161059422	H1-hESC	embryonic stem cell:	n/a	n/a
26	MAX	chr1:161059181-161059519	H1-hESC	embryonic stem cell:	n/a	n/a
27	MAX	chr1:161058897-161059658	ECC-1	luminal epithelium:	n/a	n/a
28	MAX	chr1:161059077-161059646	ECC-1	luminal epithelium:	n/a	n/a
29	MAX	chr1:161058958-161059724	MCF-7	breast:	n/a	n/a
30	MAX	chr1:161058524-161059627	MCF-7	breast:	n/a	n/a
31	MYC	chr1:161059353-161059422	MCF-7	breast:	n/a	n/a
32	MYC	chr1:161059284-161059468	MCF-7	breast:	n/a	n/a
33	NFIC	chr1:161059087-161059695	ECC-1	luminal epithelium:	n/a	n/a
34	NR2F2	chr1:161055861-161056667	MCF-7	breast:	n/a	n/a
35	NR2F2	chr1:161059085-161059661	MCF-7	breast:	n/a	n/a
36	POLR2A	chr1:161058842-161058862	MCF-7	breast:	n/a	n/a
37	POLR2A	chr1:161058888-161059609	MCF-7	breast:	n/a	n/a
38	POLR2A	chr1:161058650-161058746	MCF-7	breast:	n/a	n/a
39	POLR2A	chr1:161059164-161059476	HCT-116	colon:	n/a	n/a
40	POLR2A	chr1:161059283-161059358	ProgFib	skin:	n/a	n/a
41	POLR2A	chr1:161058868-161059019	MCF-7	breast:	n/a	n/a
42	POLR2A	chr1:161059056-161059582	MCF-7	breast:	n/a	n/a
43	POLR2A	chr1:161059221-161059474	HCT-116	colon:	n/a	n/a
44	POLR2A	chr1:161059258-161059342	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr1:161059141-161059548	ECC-1	luminal epithelium:	n/a	n/a
46	POLR2A	chr1:161056133-161056728	SK-N-MC	brain:	n/a	n/a
47	POLR2A	chr1:161059039-161059616	MCF-7	breast:	n/a	n/a
48	POLR2A	chr1:161059046-161059055	MCF-7	breast:	n/a	n/a
49	STAT1	chr1:161055996-161056816	Hela-S3	cervix:	n/a	chr1:161056541-161056553 chr1:161056432-161056444 chr1:161056243-161056254
50	STAT3	chr1:161058521-161058710	MCF10A-Er-Src	breast:	n/a	chr1:161058599-161058610

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:161059267-161059317	AG09309	skin:	n/a
2	chr1:161059429-161059479	HRCEpiC	kidney:	n/a
3	chr1:161059429-161059479	LNCaP	prostate:	n/a
4	chr1:161059267-161059317	HMEC	breast:	n/a
5	chr1:161059458-161059508	HUVEC	blood vessel:	n/a
6	chr1:161059458-161059508	PANC-1	pancreas:	n/a
7	chr1:161059267-161059317	NHBE	bronchial:	n/a
8	chr1:161059327-161059377	GM19239	blood:	n/a
9	chr1:161059327-161059377	ProgFib	skin:	n/a
10	chr1:161059327-161059377	BJ	skin:	n/a
11	chr1:161059429-161059479	ovcar-3	ovarian:	n/a
12	chr1:161059429-161059479	BE2_C	brain:	n/a
13	chr1:161059267-161059317	Hepatocyte	liver:	n/a
14	chr1:161059327-161059377	A549	lung:	n/a
15	chr1:161059267-161059317	AoSMC	blood vessel:	n/a
16	chr1:161059429-161059479	A549	lung:	n/a
17	chr1:161059458-161059508	A549	lung:	n/a
18	chr1:161059458-161059508	Jurkat	blood:	n/a
19	chr1:161059267-161059317	ProgFib	skin:	n/a
20	chr1:161059458-161059508	Hela-S3	cervix:	n/a
21	chr1:161059458-161059508	Hepatocyte	liver:	n/a
22	chr1:161059267-161059317	RPTEC	kidney:	n/a
23	chr1:161059429-161059479	AG09319	gingival:	n/a
24	chr1:161059327-161059377	GM12892	blood:	n/a
25	chr1:161059267-161059317	HAEpiC	amniotic membrane:	n/a
26	chr1:161059327-161059377	NT2-D1	testis:	n/a
27	chr1:161059267-161059317	HRPEpiC	eye:	n/a
28	chr1:161059458-161059508	HL-60	blood:	n/a
29	chr1:161059327-161059377	RPTEC	kidney:	n/a
30	chr1:161059458-161059508	ovcar-3	ovarian:	n/a
31	chr1:161059458-161059508	HRE	kidney:	n/a
32	chr1:161059327-161059377	AoSMC	blood vessel:	n/a
33	chr1:161059458-161059508	AG04450	lung:	fetal
34	chr1:161059429-161059479	NH-A	brain:	n/a
35	chr1:161059429-161059479	SK-N-SH_RA	brain:	n/a
36	chr1:161059327-161059377	HNPCEpiC	eye:	n/a
37	chr1:161059458-161059508	HEK293	kidney:	embryo
38	chr1:161059267-161059317	HCF	heart:	n/a
39	chr1:161059458-161059508	NHBE	bronchial:	n/a
40	chr1:161059267-161059317	LNCaP	prostate:	n/a
41	chr1:161059429-161059479	HMEC	breast:	n/a
42	chr1:161059429-161059479	GM19239	blood:	n/a
43	chr1:161059267-161059317	HNPCEpiC	eye:	n/a
44	chr1:161059267-161059317	CMK	blood:	n/a
45	chr1:161059327-161059377	Hela-S3	cervix:	n/a
46	chr1:161059327-161059377	HEEpiC	esophagus:	n/a
47	chr1:161059267-161059317	NH-A	brain:	n/a
48	chr1:161059267-161059317	MCF-7	breast:	n/a
49	chr1:161059429-161059479	AG04449	skin:	fetal
50	chr1:161059429-161059479	HIPEpiC	eye:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:161058303..161059850-chr1:161088511..161090425,2	MCF-7	breast:
2	chr1:161007165..161010190-chr1:161058502..161060475,3	MCF-7	breast:
3	chr1:161043647..161044411-chr1:161058609..161059385,2	MCF-7	breast:
4	chr1:160989498..160991645-chr1:161056781..161059472,2	MCF-7	breast:
5	chr1:161045029..161046710-chr1:161057509..161060408,2	K562	blood:
6	chr1:161056567..161059211-chr1:161095682..161097348,2	MCF-7	breast:
7	chr1:161014200..161017793-chr1:161057956..161063190,6	MCF-7	breast:
8	chr1:161051697..161056385-chr1:161085679..161090534,7	K562	blood:
9	chr1:161056990..161060548-chr1:161087703..161089800,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KLHDC9-1	chr1:161056693-161057335	NONHSAT007099
2	lnc-KLHDC9-1	chr1:161056693-161057361	ENSG00000228917.1

No data

Variant related genes	Relation type
PVRL4	TF binding region
PVRL4	CpG island
ENSG00000158773	chromatin interactions
ENSG00000215845	chromatin interactions
ENSG00000143217	chromatin interactions
ENSG00000270149	chromatin interactions
ENSG00000158769	chromatin interactions
ENSG00000143256	chromatin interactions
ENSG00000158793	chromatin interactions

Extended variants
information (count: 134 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:134 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185945220	chr1:161055738-161055739	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs188656626	chr1:161055754-161055755	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs181151542	chr1:161055767-161055768	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs556194878	chr1:161055809-161055810	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs12044026	chr1:161055863-161055864	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs185340965	chr1:161055873-161055874	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs562206918	chr1:161055929-161055930	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs541621275	chr1:161055970-161055971	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs370071028	chr1:161055999-161056000	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs148553102	chr1:161056066-161056067	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs77038043	chr1:161056068-161056069	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs541142857	chr1:161056088-161056089	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs527807744	chr1:161056202-161056203	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs190594777	chr1:161056212-161056213	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs12410477	chr1:161056214-161056215	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs114871329	chr1:161056215-161056216	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs563818196	chr1:161056218-161056219	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs372314841	chr1:161056242-161056243	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs549574401	chr1:161056314-161056315	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs115112101	chr1:161056353-161056354	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs533845790	chr1:161056380-161056381	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs183245726	chr1:161056381-161056382	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs532194979	chr1:161056432-161056433	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs1556258	chr1:161056455-161056456	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs539055271	chr1:161056462-161056463	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs142931782	chr1:161056480-161056481	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs71639043	chr1:161056557-161056558	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs575910597	chr1:161056577-161056578	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs368416614	chr1:161056589-161056590	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs10159127	chr1:161056618-161056619	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs376786132	chr1:161056619-161056620	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs150953584	chr1:161056633-161056634	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs369402756	chr1:161056657-161056658	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs571930889	chr1:161056660-161056661	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs547925048	chr1:161056669-161056670	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs557978106	chr1:161056681-161056682	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs578077907	chr1:161056735-161056736	Enhancers Weak transcription Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs543446082	chr1:161056771-161056772	Enhancers Weak transcription Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs371606713	chr1:161056776-161056777	Enhancers Weak transcription Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs187420790	chr1:161056802-161056803	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs570248169	chr1:161056853-161056854	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs139533085	chr1:161056871-161056872	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs543367302	chr1:161056877-161056878	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs559942345	chr1:161056931-161056932	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs528708068	chr1:161056954-161056955	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs568141675	chr1:161056959-161056960	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs11590097	chr1:161056989-161056990	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs533076208	chr1:161057053-161057054	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
49	rs553920011	chr1:161057091-161057092	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
50	rs571030504	chr1:161057102-161057103	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Liposarcoma	21253554	CNVD
Non-small cell lung cancer	21385341	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Lung cancer	18438408	CNVD
Rett syndrome	21593744	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Systemic lupus erythematosus	21956041	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	17899364	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Type 2 diabetes	19141583	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21509527	CNVD
Bladder cancer	21909424	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21611746	CNVD
Neuroblastoma	18923191	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	19287148	CNVD
Glomerulonephritis	19341492	CNVD
Systemic lupus erythematosus	18559452	CNVD
Systemic autoimmune disease	17597778	CNVD
Glomerulonephritis	17008540	CNVD
Glomerulonephritis	16482158	CNVD
Soft tissue tumor	16732325	CNVD
Cancer	17060936	CNVD
Lung cancer	16740712	CNVD
Breast cancer	21045282	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Follicular lymphoma	18703704	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20409316	CNVD
Mental retardation	17847001	CNVD
Idiopathic thrombocytopenic purpura	17827395	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:187 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:161039600-161066800	Weak transcription	Right Atrium	heart
2	chr1:161049400-161056400	Enhancers	HMEC	breast
3	chr1:161049400-161056600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr1:161050000-161057800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr1:161050200-161055800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr1:161051000-161055800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr1:161052200-161058400	Enhancers	Pancreas	Pancrea
8	chr1:161052400-161057000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr1:161052600-161055800	Enhancers	HSMM	muscle
10	chr1:161052600-161056200	Enhancers	Rectal Mucosa Donor 31	rectum
11	chr1:161052600-161056400	Enhancers	K562	blood
12	chr1:161052600-161056600	Enhancers	Fetal Intestine Large	intestine
13	chr1:161052800-161055800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr1:161052800-161056400	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr1:161053000-161056200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr1:161053000-161056800	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr1:161053200-161059200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr1:161053400-161058600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
19	chr1:161053600-161057400	Flanking Active TSS	Placenta	Placenta
20	chr1:161053600-161058800	Weak transcription	Skeletal Muscle Female	skeletal muscle
21	chr1:161053600-161063600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr1:161053800-161056000	Enhancers	Hela-S3	cervix
23	chr1:161053800-161056800	Enhancers	NHEK	skin
24	chr1:161054200-161056000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr1:161054200-161056000	Weak transcription	Lung	lung
26	chr1:161054200-161058800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr1:161054400-161056000	Weak transcription	Rectal Mucosa Donor 29	rectum
28	chr1:161054400-161056000	Enhancers	Stomach Mucosa	stomach
29	chr1:161054400-161056800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
30	chr1:161054600-161056600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr1:161054600-161057800	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr1:161054600-161057800	Weak transcription	Monocytes-CD14+_RO01746	blood
33	chr1:161054800-161056200	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr1:161055000-161056000	Weak transcription	Colonic Mucosa	Colon
35	chr1:161055000-161056200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr1:161055000-161056800	Enhancers	Duodenum Mucosa	Duodenum
37	chr1:161055000-161057200	Enhancers	Placenta Amnion	Placenta Amnion
38	chr1:161055000-161058400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
39	chr1:161055000-161058400	Weak transcription	Gastric	stomach
40	chr1:161055200-161056400	Bivalent Enhancer	HepG2	liver
41	chr1:161055200-161058400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
42	chr1:161055200-161064600	Weak transcription	Fetal Lung	lung
43	chr1:161055400-161055800	Weak transcription	H1 Cell Line	embryonic stem cell
44	chr1:161055400-161056200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr1:161055400-161056200	Weak transcription	Fetal Intestine Small	intestine
46	chr1:161055400-161057800	Weak transcription	NHDF-Ad	bronchial
47	chr1:161055400-161058000	Weak transcription	Osteobl	bone
48	chr1:161055400-161058200	Weak transcription	A549	lung
49	chr1:161055400-161058200	Weak transcription	NH-A	brain
50	chr1:161055400-161058200	Weak transcription	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links